A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice

Two recently approved PARP inhibitors provide an important new therapeutic option for patients with BRCA-mutated metastatic breast cancer. PARP inhibitors significantly prolong progression-free survival in patients, but conventional oral delivery of PARP inhibitors is hindered by limited bioavailabi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Theranostics
Hoofdauteurs: Zhang, Di, Baldwin, Paige, Leal, Ana S., Carapellucci, Sarah, Sridhar, Srinivas, Liby, Karen T.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2019
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735511/
https://ncbi.nlm.nih.gov/pubmed/31534547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.36281
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items